Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Explore which Low Cost Dividend ETF to invest in right now. We compare costs, yields, and diversification to help you decide efficiently.
27,336 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Lawmakers push for a rapid, public vote on a war powers resolution after Trump’s Iran strikes. thomas massie among re...
A major reshuffle around Microsoft and OpenAI could shift AI momentum in tech clouds. This article explains why amazo...
Gas prices hover near fresh highs as families hit the road for the summer travel rush. A simple trio—drive slower, el...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
A new open-source coalition backed by Mozilla is mobilizing policymakers and investors to curb Big Tech’s control ove...
Toncoin surged 36% after Telegram pledged near-zero fees, sparking a broader rally in TON-related tokens. This articl...
Inflation keeps squeezing retirees who rely on fixed incomes. This guide shares three practical income moves to prote...
In a high-stakes clash of industry voices, Ripple's Brad Garlinghouse pushes back against Jamie Dimon's crypto cautio...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...